Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
10.07
+0.50 (5.22%)
Apr 25, 2025, 4:00 PM EDT

Astellas Pharma Revenue

In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T JPY with 19.25% growth. Astellas Pharma had revenue of 459.29B in the quarter ending March 31, 2025, with 10.78% growth.

Revenue
1,912.32B JPY
Revenue Growth
+19.25%
P/S Ratio
1.40
Revenue / Employee
129.61M JPY
Employees
14,754
Market Cap
17.84B USD

Revenue Chart

* This company reports financials in JPY.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20251,912.32B308.65B19.25%
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 20211,249.53B-51.32B-3.94%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition